Efficacy and Safety of Tocilizumab for TAO
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Tocilizumab
Related studies linked through entity extraction aliases.
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
- Status
- RECRUITING
- Phase
- PHASE2
Tocilizumab in Lung Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
- Status
- RECRUITING
- Phase
- PHASE1
LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients
- Status
- RECRUITING
- Phase
- PHASE1
"Comparison of the Efficacy and Safety of Adalimumab to That of Tocilizumab in Severe Uveitis of Behçet's Disease"
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and ASCT-related Symptom Burden Optimization of Tocilizumab in ASCT Following HD Melphalan Conditioning for Multiple Myeloma Patients
- Status
- UNKNOWN
- Phase
- PHASE4
SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
- Status
- RECRUITING
- Phase
- PHASE2
A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosus
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure.
- Status
- RECRUITING
- Phase
- PHASE2
Study of RO7515629 in Participants With HLA-G Positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination With Cevostamab in Participants With Relapsed/Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Tocilizumab for Acute Chest Syndrome
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
- Status
- COMPLETED
- Phase
- PHASE1